You can say that for so very many stocks on the ASX.
Sadly cannot eat or spend potential.
This is certainly a very positive step in the right direction.
I love the technology here, and the products are desperately needed - but I see a massive black hole that needs to be filled with money before they can get this to a stage of delivering a return, either capital or yield.
Still watching and keeping fingers crossed.
GLTA
Cabe
Ann: US FDA Grants Qualified Infectious Disease Product Designati, page-4
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $118.1M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 46.5¢ | 46.5¢ | $2.131K | 4.582K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1263 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 11173 | 5 |
View Market Depth
| Last trade - 12.38pm 04/12/2024 (20 minute delay) ? |
| RCE (ASX) Chart |
